Unlock the full picture

First things first, the sad loss of life and any injuries should be the main focus. There is nothing like seeing photographs of some of the victims, as Tom has, to bring home the personal tragedies involved. It was an act of evil and will hopefully lead to a much stronger security ring around the site going forward.Turning to the less important, but still legitimate, shareholder issues, I have received a direct response from Sam Wells on behalf of Lycopodium regarding its physical presence at Tulu Kapi.He stated: “From the Company’s perspective, the natural order of progression (based on their scope) is to likely not have been onsite at this project until sometime in 2027, and always subject to all of the Company’s premobilisation requirements.”That sits very awkwardly with KEFI’s 4 August RNS, which stated that Lycopodium, EEP, ERA and BCM were: “installing their own personnel, subcontractors and systems at Tulu Kapi” and were: “intensively mobilising personnel, subcontractors and systems on the ground.”On any ordinary reading, KEFI’s wording conveyed that Lycopodium was part of the physical mobilisation taking place at Tulu Kapi at that time. Lycopodium now says its natural progression was that it would likely not even be on site until sometime in 2027. That is a serious discrepancy between KEFI’s 4 August RNS and Lycopodium’s account which Kefi should explain. I have asked KEFI several times to provide answers on their Q&A to explain the discrepancy.The obvious questions are: what precisely was KEFI referring to in relation to Lycopodium on 4 August, which principal contractors were actually physically active at Tulu Kapi, and did any of that activity reduce or cease before 4 September? There may be a straightforward explanation, but shareholders are entitled to one.

:)Nice one Tom but still, you are quoting generic statistics and probability of success. Avacta is using warheads that are already proven. Hence one of the reasons the FDA granted them a pivotal phase 2 trial for generation 1 drug. When you have warheads already proven, that derisks phase 3 massively. Do you not understand that? Because that alone is just one of many things you are missing about avacta and its probability of success and therefore its risk asjusted net present value. Effectively warhead proven before they even start the trial, increasing probability of success way beyond that of a generic POS. Now they've proven safety multiple times in multiple patients with 2 highly toxic warheads.Anyway, I can only conclude you either dont understand or dont want to understand? My offer is genuine to help educate you but if youre not interested, fine. Good luck with your African gold mines and modular housing in South America which are far less risky than a heavily scrutinised and regulated British biotech 👍

That is an admission I would not make on BBs if I were you. Another piece on way!

I personally think that the CoS in a repurposed targeted version of an approved efficacious existing product is higher than a de novo candidate.But the issue here is that there needs fairly soon to be a £25m raise. The key issue is whether there is any industry ratification of the precision platform at this point. If there is, in the form of a deal with an upfront, then tick, a smaller capital raise can be done.If no industry ratification with cash attached, then yet another plain vanilla raise will be a very bloody affair.Comes down to industry ratification at this point (or not). It’s the swing factor.

Incorrect, I said it’s a possibility, which it is. If you want to keep making things up to justify your conformation bias, that’s your call.

Per CH, oily was the sole director of Oak Securities and a 75%+ PSC. Not filed accounts as it is having an 18 months accounting period????

Fair play for letting that be posted. I do like you Tom 😅Listen, genuinely, if you want to talk or learn more about Avacta science you only need to reach out to me. I am more than willing to help.Lets see where we fall with funding anyway, you may well be right about that 👍

ive asked him if he has a view